Needs assessment and expected educational outcome

To update evaluations for iron deficiency and therapeutic iron supplementation, according to the new 2021 ESC/HFA Guidelines for Heart Failure; to gain insights from the AFFIRM-AHF trial; to learn about cost effectiveness of iron supplementation in HF patients; and to learn the effect of iron supplementation on exercise capacity and QoL.

Learning objectives

After watching this webinar, participants will :

be updated on the epidemiology of hypokalaemia and hyperkalaemia;
learn when and how to monitor/measure K levels in heart failure; and
learn how to evaluate management options in patients at risk of hyperkalaemia, including new therapies that may improve adherence and treatment optimisation in patients with heart failure and high K levels.

ESC 365 is supported by